Aeterna Zentaris, a specialty biopharmaceutical company, is a party to a license and assignment agreement with a subsidiary of Novo Nordisk A/S to carry out development, manufacturing, registration and commercialization of Macrilen™ (macimorelin), an oral ghrelin receptor agonist to be administered in the diagnosis of patients with adult growth hormone deficiency, in the United States and Canada. 

Pharmaceutical

Zentaris

Klaus Paulini

Matt Killick, CPA, CA

Verena Weyrauch

Paul Burroughs

Mile Obradovic

Michael Teifel

Giuliano La Fratta, CPA, CA

Dr. Eckhard Guenther

Di Stefano Dominique

Daniela Maier

Eckhard G. Guenther

Nicola Ammer

Finance and Administration Team

Leadership Team

Clinical Development Team

Teams at Zentaris

Finance and Administration Team

Leadership Team

Clinical Development Team